Companies sponsors |
Novartis (tisagenlecleucel) |
Others |
Department of Health and Social Care |
|
NHS England |
Patient carer groups |
Anthony Nolan |
|
Blood Cancer UK |
|
Leukaemia Care |
Professional groups |
Association of Cancer Physicians |
|
Cancer Research UK |
|
Royal College of Physicians |
|
Royal College of Radiologists |
Comparator companies |
AAH Pharmaceuticals Ltd – CAU not returned, not participating |
|
Accord Healthcare Ltd – CAU not returned, not participating |
|
Alliance Healthcare Ltd – CAU not returned, not participating |
|
Amgen Ltd – CAU not returned, not participating |
|
Bristol-Myers Squibb Pharmaceutical Limited – CAU not returned, not participating |
|
Chugai Pharma UK Ltd – CAU not returned, not participating |
|
Consilient Health Ltd – CAU not returned, not participating |
|
Dr. Reddy's Laboratories (UK) Ltd – CAU not returned, not participating |
|
Esteve Pharmaceuticals Ltd – CAU not returned, not participating |
|
Incyte BioSciences UK Ltd – CAU not returned, not participating |
|
Napp Pharmaceuticals Ltd – CAU not returned, not participating |
|
Novartis Pharmaceuticals Ltd (imatinib) |
|
Pfizer Ltd – CAU not returned, not participating |
|
Sandoz Ltd – CAU not returned, not participating |
|
Sanofi – CAU not returned, not participating |
|
Teva Pharma B.V – CAU not returned, not participating |
|
Tillomed Laboratories Ltd – CAU not returned, not participating |
|
Viatris UK Healthcare Ltd – CAU not returned, not participating |
|
Zentiva Pharma Ltd – CAU not returned, not participating |
General commentators |
All Wales Therapeutics and Toxicology Centre |
|
British National Formulary |
|
Healthcare Improvement Scotland |
|
Medicines and Healthcare products Regulatory Agency |
|
Scottish Medicines Consortium |
|
Welsh Government |
|
Welsh Health Specialised Services Committee |
Relevant research groups |
Institute of Cancer Research |